8A-PDHQ
化合物
8A-PDHQ(全稱:8a-苯基十氫喹啉,英語:8a-Phenyldecahydroquinoline)是一種含氮有機化合物,分子式C15H21N,可作為NMDA受體拮抗劑,1950年代由Parke-Davis開發[1][2][3]。
識別資訊 | |
---|---|
| |
CAS號 | 131556-11-1 |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
化學資訊 | |
化學式 | C15H21N |
摩爾質量 | 215.34 g·mol−1 |
3D模型(JSmol) | |
| |
|
參考文獻
- ^ US Patent 3035059
- ^ Chen, C; Kozikowski, AP; Wood, PL; Reynolds, IJ; Ball, RG; Pang, YP. Synthesis and biological activity of 8a-phenyldecahydroquinolines as probes of PCP's binding conformation. A new PCP-like compound with increased in vivo potency.. Journal of medicinal chemistry. 1992-05-01, 35 (9): 1634–8. PMID 1315871. doi:10.1021/jm00087a020.
- ^ Elhallaoui, M; Laguerre, M; Carpy, A; Ouazzani, FC. Molecular modeling of noncompetitive antagonists of the NMDA receptor: proposal of a pharmacophore and a description of the interaction mode.. Journal of molecular modeling. 2002-02, 8 (2): 65–72. PMID 12032600. doi:10.1007/s00894-001-0067-4.